Type 2 Diabetes
Showing NaN - NaN of 74
Type 2 Diabetes Trial in Chicago (Intensive education and lifestyle support, Standard of Care control group)
Completed
- Type 2 Diabetes
- Intensive education and lifestyle support
- Standard of Care control group
-
Chicago, IllinoisCook County Health Clinics
May 8, 2017
Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin
Completed
- Type 2 Diabetes
- Insulin glargine/lixisenatide (HOE901/AVE0010)
- +2 more
-
Birmingham, Alabama
- +235 more
Mar 31, 2017
Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),
Completed
- Type 2 Diabetes
- Insulin glargine/lixisenatide Fixed Ratio Combination
- +3 more
-
Phoenix, Arizona
- +272 more
Mar 31, 2017
Obstructive Sleep Apnea, Type 2 Diabetes Trial in Chicago (active CPAP Therapy, sham CPAP therapy)
Completed
- Obstructive Sleep Apnea
- Type 2 Diabetes
- active CPAP Therapy
- sham CPAP therapy
-
Chicago, IllinoisThe University of Chicago
Feb 24, 2017
Type 2 Diabetes, Renal Insufficiency Trial in Chicago, Maywood (0.5 units/kg daily insulin, 0.25 units/kg daily insulin)
Completed
- Type 2 Diabetes
- Renal Insufficiency
- 0.5 units/kg daily insulin
- 0.25 units/kg daily insulin
-
Chicago, Illinois
- +2 more
Mar 9, 2017
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Metformin XR)
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Type 2 Diabetes Trial in Worldwide (ITCA 650, ITCA )
Completed
- Type 2 Diabetes
- ITCA 650
- ITCA placebo
-
Chandler, Arizona
- +41 more
Jan 26, 2017
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)
Completed
- Type 2 Diabetes
- Dapagliflozin
- Placebo-matching dapagliflozin
-
Birmingham, Alabama
- +328 more
Dec 2, 2016
Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID)
Completed
- Type 2 Diabetes
- Lixisenatide (AVE0010)
- +4 more
-
Sun City, Arizona
- +198 more
Nov 4, 2016
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)
Completed
- Type 2 Diabetes
- Dapagliflozin
- Placebo matching Dapagliflozin
-
Birmingham, Alabama
- +297 more
Nov 10, 2016
Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching with Dapagliflozin, Saxagliptin)
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Obesity, Cardiovascular Disease, Type 2 Diabetes Trial in Chicago (Sleeve Gastrectomy)
Completed
- Obesity
- +4 more
- Sleeve Gastrectomy
-
Chicago, IllinoisNorthwestern University
Sep 30, 2015
Type 2 Diabetes Trial in United States (ITCA 650, ITCA )
Completed
- Type 2 Diabetes
- ITCA 650
- ITCA placebo
-
Birmingham, Alabama
- +121 more
Jul 28, 2015
Type 2 Diabetes Trial in United States (Mitoglitazone, Pioglitazone, Placebo)
Type 2 Diabetes, Hypogonadism Trial in United States (Androgel (testosterone gel))
Completed
- Type 2 Diabetes
- Hypogonadism
- Androgel (testosterone gel)
-
Birmingham, Alabama
- +69 more
Jan 19, 2015
A 2-Month Safety Follow-Up Trial
Completed
- Type 1 Diabetes
- Type 2 Diabetes
- Technosphere Insulin Inhalation Powder
- Comparator
-
Birmingham, Alabama
- +149 more
Dec 1, 2014
Postpartum Glucose Tolerance With Levonorgesterel IUD Use in
Completed
- Gestational Diabetes
- +3 more
- Mirena (Levonorgestrel IUD)
- Paragard (Copper IUD ) or Tubal Ligation
-
Chicago, IllinoisNorthwestern Medical Faculty Foundation; Northwestern Memorial H
Nov 19, 2014